← Back to headlines
AbbVie’s Skyrizi beaten by UCB’s Bimzelx in psoriatic arthritis
UCB's drug Bimzelx has outperformed AbbVie's Skyrizi in treating psoriatic arthritis.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
1h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
5h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
11h ago